Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FIBROGEN INC Director's Dealing 2016

May 18, 2016

34576_dirs_2016-05-18_e9a8f2e6-ae2a-4463-9ab6-ec9e29eea75f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2016-05-16

Reporting Person: Cotroneo Pat (VP, Finance and CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-05-16 Common Stock S 6107 $17.60 Disposed 141868 Direct

Footnotes

F1: Shares sold pursuant to a 10b5-1 plan.

F2: The shares were sold at prices ranging from $17.35 to $17.95. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Includes 1,389 shares purchased through the issuer's employee stock purchase plan on May 13, 2016.